• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2; INTRAOCULAR PRESSURE LOWERING IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2; INTRAOCULAR PRESSURE LOWERING IMPLANT Back to Search Results
Model Number IS2-JP
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/01/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that following the successful implantation of the first stent and subsequent deployment of the second stent from a trabecular microbypass stent system, "a stent and a metal fragment" were observed inside the patient's right eye (od).Per report, the second stent and the fragment were removed intraoperatively with no report of injury, and a back-up device was used to complete the procedure.The report noted that after the first stent was implanted, a stent was placed at the tip of the "fractured trocar" which became lodged between the tube and the trocar, and the surgeon believes the trocar broke due to pressure applied during deployment.Additional information has been requested.
 
Additional Manufacturer Narrative
Additional information: the device has been returned to glaukos for evaluation, and the investigation is underway.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A complaint history review was completed.The electronic complaint system was searched for the specified lot#.There were no similar issues reported for this lot #.A review of the device labeling including the risk analysis was completed.The reported issue (trocar fragmentation) is identified to be an anticipated hazard.The residual risk for each potential harm was found to be within the insignificant risk region.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.Mfr# reference: (b)(4).
 
Additional Manufacturer Narrative
Mfr# reference: (b)(4).
 
Event or Problem Description
Through follow-up, the following additional information was received.Per report, the patient¿s condition is stable with no postoperative bleeding, no issues with visual acuity, and intraocular pressure (iop) in the low teens.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2
Common Device Name
INTRAOCULAR PRESSURE LOWERING IMPLANT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer (Section G)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
brittany massey
229 avenida fabricante
san clemente, CA 92672
949367960
MDR Report Key24973584
Report Number2032546-2026-00029
Device Sequence Number16066197
Product Code OGO
UDI-Device Identifier00853704002487
UDI-Public01008537040024871033023117270831
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P170043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/22/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberIS2-JP
Device Lot Number330231
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/16/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/01/2026
Supplement Date Received by Manufacturer04/27/2026
06/17/2026
Initial Report FDA Received Date04/23/2026
Supplement Report FDA Received Date05/18/2026
06/22/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/22/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-